Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (Tbeta4), analogues, isoforms and other derivatives

Details for Australian Patent Application No. 2002255736 (hide)

Owner Regenerx, Biopharmaceuticals, Inc.

Inventors Goldstein, Allan L.

Agent Wrays

Pub. Number AU-B-2002255736

PCT Pub. Number WO2002/074193

Priority 60/275,645 15.03.01 US

Filing date 14 March 2002

Wipo publication date 3 October 2002

Acceptance publication date 31 August 2006

International Classifications

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002255736

31 August 2006 Application Accepted

  Published as AU-B-2002255736

4 January 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002255737-METHOD AND EVAPORATING SOLUTION FOR RINSING A DEVELOPED PHOTORESIST LAYER

2002255735-A SYSTEM AND METHOD FOR RETRIEVING AND USING GENE EXPRESSION DATA FROM MULTIPLE SOURCES